Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127072061 | 12707206 | 1 | I | 20070707 | 20070821 | 20160901 | 20160901 | EXP | US-PFIZER INC-2007068895 | PFIZER | 60.00 | YR | F | Y | 92.08000 | KG | 20160901 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127072061 | 12707206 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | N | 18989 | TABLET | ||||||||
| 127072061 | 12707206 | 2 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 3 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 5 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 6 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 7 | C | DARVOCET | ACETAMINOPHENPROPOXYPHENE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 8 | C | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 10 | C | DIPHENHYDRAMINE HYDROCHLORIDE. | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 11 | C | ZINC | ZINCINC CHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 12 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 13 | C | CALCIUM CITRATE | CALCIUM CITRATE | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 14 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 15 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | UNK | 0 | ||||||||||
| 127072061 | 12707206 | 16 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127072061 | 12707206 | 1 | Osteoarthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127072061 | 12707206 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127072061 | 12707206 | Hypertensive nephropathy | |
| 127072061 | 12707206 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127072061 | 12707206 | 1 | 20070417 | 20070707 | 0 | |
| 127072061 | 12707206 | 2 | 20070417 | 20070707 | 0 | |
| 127072061 | 12707206 | 3 | 1987 | 0 | ||
| 127072061 | 12707206 | 4 | 1999 | 20070626 | 0 | |
| 127072061 | 12707206 | 5 | 1992 | 0 | ||
| 127072061 | 12707206 | 6 | 2002 | 0 | ||
| 127072061 | 12707206 | 7 | 1995 | 0 | ||
| 127072061 | 12707206 | 8 | 2000 | 0 | ||
| 127072061 | 12707206 | 9 | 2004 | 20070707 | 0 | |
| 127072061 | 12707206 | 10 | 2005 | 0 | ||
| 127072061 | 12707206 | 11 | 200702 | 0 | ||
| 127072061 | 12707206 | 12 | 2000 | 0 | ||
| 127072061 | 12707206 | 13 | 200505 | 0 | ||
| 127072061 | 12707206 | 14 | 200505 | 0 | ||
| 127072061 | 12707206 | 15 | 2005 | 0 | ||
| 127072061 | 12707206 | 16 | 20070612 | 20070712 | 0 |